To scroll text in this page

Global Navigation
Global Navigation end

About Astellas

Start of the main text

2018 News Releases

About RSS

Astellas Announce Top-Line Results for Two Phase 3 Trials of Peficitinib in Rheumatoid Arthritis Patients with Inadequate Response to Existing Therapy(pdf 249 KB)

February 8, 2018

Printer-friendly version

Main Text end
Local Navigation
Local Navigation end
Related Links